Alternation of histone and DNA methylation in human atherosclerotic carotid plaques

 

 Buy Article Permissions and Reprints

Summary

Little is known about epigenetics and its possible role in atherosclerosis. We here analysed histone and DNA methylation and the expression of corresponding methyltransferases in early and advanced human atherosclerotic carotid lesions in comparison to healthy carotid arteries. Western Blotting was performed on carotid plaques from our biobank with early (n=60) or advanced (n=60) stages of atherosclerosis and healthy carotid arteries (n=12) to analyse di-methylation patterns of histone H3 at positions K4, K9 and K27. In atherosclerotic lesions, di-methylation of H3K4 was unaltered and that of H3K9 and H3K27 significantly decreased compared to control arteries. Immunohistochemistry revealed an increased appearance of di-methylated H3K4 in smooth muscle cells (SMCs), a decreased expression of di-methylated H3K9 in SMCs and inflammatory cells, and reduced di-methylated H3K27 in inflammatory cells in advanced versus early atherosclerosis. Expression of corresponding histone methyltransferases MLL2 and G9a was increased in advanced versus early atherosclerosis. Genomic DNA hypomethylation, as determined by PCR for methylated LINE1 and SAT-alpha, was observed in early and advanced plaques compared to control arteries and in cell-free serum of patients with high-grade carotid stenosis compared to healthy volunteers. In contrast, no differences in DNA methylation were observed in blood cells. Expression of DNA-methyltransferase DNMT1 was reduced in atherosclerotic plaques versus controls, DNMT3A was undetectable, and DNMT3B not altered. DNA-demethylase TET1 was increased in atherosclerosisc plaques. The extent of histone and DNA methylation and expression of some corresponding methyltransferases are significantly altered in atherosclerosis, suggesting a possible contribution of epigenetics in disease development.

^{* and #} equal contribution.

• References

• 1 Nimura K, Ura K, Kaneda Y. Histone methyltransferases: regulation of transcription and contribution to human disease. J Mol Med 2010; 88: 1213-1220.
  CrossrefPubMedGoogle Scholar
• 2 Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 2010; 11: 607-620.
  PubMedGoogle Scholar
• 3 Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet 2009; 43: 559-599.
  CrossrefPubMedGoogle Scholar
• 4 Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 2009; 49: 243-263.
  CrossrefPubMedGoogle Scholar
• 5 Szyf M. Targeting DNA methylation in cancer. Bull Cancer 2006; 93: 961-972.
  PubMedGoogle Scholar
• 6 Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10: 295-304.
  CrossrefPubMedGoogle Scholar
• 7 Kondo Y. Epigenetic cross-talk between DNA methylation and histone modifications in human cancers. Yonsei Med J 2009; 50: 455-463.
  CrossrefPubMedGoogle Scholar
• 8 Ivanova T, Vinokurova S, Petrenko A. et al. Frequent hypermethylation of 5’ flanking region of TIMP-2 gene in cervical cancer. Int J Cancer 2004; 108: 882-886.
  CrossrefPubMedGoogle Scholar
• 9 Boumber Y, Issa JP. Epigenetics in cancer: what’s the future?. Oncology 2011; 25: 220-226.
  PubMedGoogle Scholar
• 10 Shima K, Morikawa T, Baba Y. et al. MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers. Cancer Causes Control 2011; 22: 301-309.
  CrossrefPubMedGoogle Scholar
• 11 Pavicic W, Joensuu EI, Nieminen T, Peltomäki P. LINE-1 hypomethylation in familial and sporadic cancer. J Mol Med 2012; 90: 827-835.
  CrossrefPubMedGoogle Scholar
• 12 Dong C, Yoon W, Goldschmidt-Clermont PJ. DNA Methylation and Atherosclerosis. J Nutr 2002; 132: 2406S-2409S.
  CrossrefPubMedGoogle Scholar
• 13 Castillo-Díaz SA, Garay-Sevilla ME, Hernández-González MA. et al. Extensive demethylation of normally hypermethylated CpG islands occurs in human atherosclerotic arteries. Int J Mol Med 2010; 26: 691-700.
  PubMedGoogle Scholar
• 14 Turunen MP, Ylä-Herttuala S. Epigenetic regulation of key vascular genes and growth factors. Cardiovasc Res 2011; 90: 441-446.
  CrossrefPubMedGoogle Scholar
• 15 Ordovás JM, Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol 2010; 7: 510-519.
  CrossrefPubMedGoogle Scholar
• 16 Hiltunen MO, Turunen MP, Häkkinen TP. et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 2002; b7: b5-11.
  CrossrefPubMedGoogle Scholar
• 17 Baccarelli A, Tarantini L, Wright RO. et al. Repetitive element DNA methylation and circulating endothelial and inflammation markers in the VA normative aging study. Epigenetics 2010; 05: 222-228.
  CrossrefPubMedGoogle Scholar
• 18 Choi SH, Heo K, Byun HM. et al. Identification of preferential target sites for human DNA methyltransferases. Nucleic Acids Res 2011; 39: 104-118.
  CrossrefPubMedGoogle Scholar
• 19 Timaran CH, McKinsey JF, Schneider PA. et al. Reporting standards for carotid interventions from the Society for Vascular Surgery. J Vasc Surg 2011; 53: 1679-1695.
  CrossrefPubMedGoogle Scholar
• 20 Stary HC, Chandler AB, Glagov S. et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Circulation 1994; 89: 2462-2478.
  CrossrefPubMedGoogle Scholar
• 21 Stary HC, Chandler AB, Dinsmore RE. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation 1995; 92: 1355-1374.
  CrossrefPubMedGoogle Scholar
• 22 Reeps C, Pelisek J, Seidl S. et al. Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiology 2009; 76: 243-252.
  CrossrefPubMedGoogle Scholar
• 23 Pelisek J, Well G, Reeps C. et al. Neovascularization and angiogenic factors in advanced human carotid artery stenosis. Circ J 2012; 76: 1274-1282.
  CrossrefPubMedGoogle Scholar
• 24 Lipp C, Lohoefer F, Reeps C. et al. Expression of a disintegrin and metallopro-tease in human abdominal aortic aneurysms. J Vasc Res 2012; 49: 198-206.
  CrossrefPubMedGoogle Scholar
• 25 Weisenberger DJ, Campan M, Long TI. et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic acids Res 2008; 33: 823-836.
  PubMedGoogle Scholar
• 26 Santos-Rosa H, Caldas C. Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 2005; 41: 2381-2402.
  CrossrefPubMedGoogle Scholar
• 27 Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc 1995; 57: 298-300.
  PubMedGoogle Scholar
• 28 Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, Califano JA, Goodman SN, Westra WH, Hoque MO. et al. An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 2011; 17: 4494-4503.
  CrossrefPubMedGoogle Scholar
• 29 de Martino M, Klatte T, Haitel A. et al. Serum cell-free DNA in renal cell carcinoma: a diagnostic and prognostic marker. Cancer 2012; 118: 82-90.
  CrossrefPubMedGoogle Scholar
• 30 Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 2012; 13: 343-357.
  CrossrefPubMedGoogle Scholar
• 31 Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 2012; 74: 13-40.
  CrossrefPubMedGoogle Scholar
• 32 Martin Cl, Zhang Y. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005; 06: 838-849.
  CrossrefPubMedGoogle Scholar
• 33 Rose CM, van den Driesche S, Meehan RR. et al. Epigenetic reprogramming: preparing the epigenome for the next generation. Biochem Soc Trans 2013; 41: 809-814.
  CrossrefPubMedGoogle Scholar
• 34 Bessler JBl, Andersen EC, Villeneuve AM. Differential localization and independent acquisition of the H3K9me2 and H3K9me3 chromatin modifications in the Caenorhabditis elegans adult germ line. PLoS Genet 2010; 06: e1000830.
  CrossrefPubMedGoogle Scholar
• 35 Lacolley P, Regnault V, Nicoletti A, Li Z. et al. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 2012; 95: 194-204.
  CrossrefPubMedGoogle Scholar
• 36 Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90: 251-262.
  PubMedGoogle Scholar
• 37 Manabe I, Owens GK. Recruitment of serum response factor and hyperacetylation of histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-derived in vitro smooth muscle differentiation system. Circ Res 2001; 88: 1127-1134.
  CrossrefPubMedGoogle Scholar
• 38 De Santa F, Totaro MG, Prosperini E. et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007; 130: 1083-1094.
  CrossrefPubMedGoogle Scholar
• 39 Ruthenburg AJ, Allis CD, Wysocka J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 2007; 25: 15-30.
  CrossrefPubMedGoogle Scholar
• 40 Andreu-Vieyra CV, Chen R, Agno JE. et al. MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing. PLoS Biol 2010; 08: e1000453.
  CrossrefPubMedGoogle Scholar
• 41 Spin JM, Quertermous T, Tsao PS. Chromatin remodeling pathways in smooth muscle cell differentiation, and evidence for an integral role for p300. PLoS One 2010; 05: e14301.
  CrossrefPubMedGoogle Scholar
• 42 Tahiliani M, Koh KP, Shen Y. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324: 930-935.
  CrossrefPubMedGoogle Scholar
• 43 Wu H, Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev 2011; 25: 2436-2452.
  CrossrefPubMedGoogle Scholar
• 44 Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009; 324: 929-930.
  CrossrefPubMedGoogle Scholar
• 45 Stenvinkel P, Karimi M, Johansson S. et al. Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease?. J Intern Med 2007; 261: 488-499.
  CrossrefPubMedGoogle Scholar
• 46 Qi J, Qian C, Shi W. et al. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer. Clin Biochem. 2013; 46: 64-69.
  CrossrefPubMedGoogle Scholar
• 47 Yu J, Gu G, Ju S. Recent advances in clinical applications of circulating cell-free DNA integrity. Lab Med 2014; 45: 6-11.
  CrossrefPubMedGoogle Scholar
• 48 Martinet W, Schrijvers DM, De Meyer GR. Necrotic cell death in atherosclerosis. Basic Res Cardiol 2011; 106: 749-760.
  CrossrefPubMedGoogle Scholar
• 49 Liuzzo G, Giubilato G, Pinnelli M. T cells and cytokines in atherogenesis. Lupus 2005; 14: 732-735.
  CrossrefPubMedGoogle Scholar
• 50 Tamaru H, Selker EU. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 2001; 414: 277-283.
  CrossrefPubMedGoogle Scholar
• 51 Wang J, Hevi S, Kurash JK. et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 2009; 41: 125-129.
  CrossrefPubMedGoogle Scholar

• Supplementary Material